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Atrial Natriuretic Factor 
Edwards and colleagues' evidence (1) further advances our under-
standing of atrial natriuretic factor by identifying this polypeptide 
(or group of polypeptides) (2) in the ventricle and its relation to 
ventricular dilation. Yet, the role of transmural pressure (rather than 
"filling" pressure) is not as clear here as it is in the atrium, where 
despite very high intracavitary pressure, the average transmural 
pressure can be effectively small to zero-as in cardiac tamponade 
and constriction (3)-the expression of atrial natriuretic factor is 
drastically reduced (2). The authors established their evidence for 
ventricular production of atrial natriuretic factor as being indepen-
dent of static chamber dilation. But atrial natriuretic factor produc-
tion is minimized in cardiac tamponade and constriction because the 
atria cannot dynamically dilate and filling is greatly reduced (atrial 
and wedge pressures despite their high levels are thus not really 
"filling" pressures) (3). It would be of considerable interest to know 
if the authors have evidence on ventricular atrial natriuretic factor 
production during pericardial compression of a diseased ventricle. 
That is, is the stimulus stretch, as in the atrium, rather than dilation? 
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Reply 
Although atrial natriuretic factor is not present in the normal 
ventricle, we have observed its expression in ventricular tissue from 
patients with both restrictive and dilated disorders. 
In regard to the role of transmural pressure, it is important to 
make a distinction between release of atrial natriuretic factor and 
induction of atrial natriuretic factor gene expression. As we have 
previously reported (1), increased atrial transmural pressure results 
in an acute increase in plasma atrial natriuretic factor. This obser-
vation demonstrates release of atrial natriuretic factor and does not 
evaluate peptide synthesis. We have previously observed that in 
congestive heart failure, there exists an inverse relation between 
atrial atrial natriuretic factor content and circulating levels of the 
peptide (2). To our knowledge, no study has examined the relation 
between ventricular atrial natriuretic factor tissue content and 
circulating levels in states in which the pericardium compresses a 
diseased ventricle. When the existence of ventricular atrial natri-
uretic factor was first reported in the dilated human heart (3), we 
observed a concentration gradient, such that the suberidocardial 
tissue contained more atrial natriuretic factor than did the subepi-
cardial regions of the ventricle. In evaluating the relation between 
ventricular atrial natriuretic factor content and wall stress, average 
transmural stress may not accurately reflect the situation. Ritman 
and colleagues (4) have demonstrated a transmural gradient in 
myocardial stress-strain relation. In diseased states the subendocar-
dial region of the left ventricle is the area richest in ventricular atrial 
natriuretic factor and is also the atea of highest myocardial stress. 
This observation and our previous observation that ventricular atrial 
natriuretic factor appears to occur in states in which left ventricular 
end-diastolic pressure is elevated, demonstrate interesting arid im-
portant correlations; however, further work will be required to 
ultimately demonstrate the mechanisms responsible for these rela-
tions. 
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